Staff editor
Maria Lluch Senar, Founder and Chief Scientific Officer at Pulmobiotics SL, discusses the research on engineering Live Biotherapeutics in order to expose antigens or deliver therapeutic agents to treat complex…
The study seeks to identify specific microbial and metabolic markers in the small intestinal fluid and blood of PD patients, offering new avenues for therapeutic intervention.
Shahram Lavasani, Founder & CEO at ImmuneBiotech AB, discusses the recent data about gut microbiota and Pre-eclampsia.
Giovanni Barbara, congress chair, explain why it is important to be part of IBS Days 2024.
Two pioneering companies are poised to explore the genetic frontiers of probiotic bacteria, seeking out strains that can produce sustainable quantities of life-enhancing microbial metabolites.
Industry
Sponsored by
Novozymes and Chr. Hansen have successfully merged to form Novonesis, heralding a new chapter in sustainable business practices and environmental stewardship.
Alessio Fasano gives an overview of the IHMC Congress to be held in Rome, 22-25 June.
Underpinning this partnership is a shared vision championed by both entities, emphasizing the interconnectedness of human, animal, and ecosystem health—a concept central to the 'One Health' approach.
Industry
Sponsored by
Join SynBalance, platinum sponsor at Probiota Global 2024 (7-9 February, Milan), and discover the newst scientific data on ProBeautyShield, the probiotic ingredient designed for skin health.
Their work in engineering bacteriophages to target pathogenic bacteria represents a significant leap in treating bacterial and inflammatory diseases.
